Delivery Order HHSN261201500042I-75N91018F00003
Award Date
8/8/18
Potential Completion Date
2/7/22
Potential Value
$971K
Federal Agency
National Cancer Institute
Awardee
IIT Research Institute
Ultimate Awardee
Illinois Institute Of Technology
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60616, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI) to IIT Research Institute (IITRI), a non-profit preclinical contract research organization (CRO). The contract is for $532,562.26 to evaluate a breast cancer prevention agent under the PREVENT Cancer Preclinical Drug Development Program, a $149.995 million NCI Indefinite Delivery Vehicle (IDV) that IITRI holds. IITRI has extensive experience providing preclinical drug development services to federal agencies...
This federal contract award with award ID HHSN261201500024I|HHSN26100003 was issued by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS). The $321,110.80 award was made on September 15, 2016 to the IIT Research Institute (IITRI), a non-profit research organization and division of the Illinois Institute of Technology (IIT). The contract is for the "PRECLINICAL EVALUATION OF A NEW LIPID-BASED SMEDDS" under the NCI's PREVENT...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $2,398.74 delivery order against the PREVENT Preclinical Drug Development Program indefinite-delivery/indefinite-quantity master contract to IIT Research Institute. IIT Research Institute, a subsidiary of the Illinois Institute Of Technology Sponsored Research And Programs Division, will provide a "CONTRACT ORIENTATION AND KICKOFF MEETING" as the prime contractor. The...
This federal contract award was issued by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology (IIT). The $1,405,361.18 delivery order contract supports the PREVENT Preclinical Drug Development Program, a significant $150 million multiple-award IDIQ contract with NCI. Under this task order, IITRI will provide topical resatorvid for nonmelanoma skin cancer prevention research during the period of September 2020 to...
This is a $718,265.00 delivery order awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to IIT Research Institute, the research and technology development arm of Illinois Institute of Technology (IIT). The contract supports preclinical toxicology and pharmacology research for drugs developed for cancer patients, including exploratory studies of CCR4 CAR T cells. This work is performed under the NCI's "Toxicology of Drugs Developed for...
This federal contract award from the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a division of the Illinois Institute of Technology, is for a $596,209 Firm Fixed Price Delivery Order under the "PREVENT Cancer Program (PREVENT)" contract vehicle. The contract is for the "NOVEL ANDROGEN RECEPTOR ANTAGONIST-MEDIATED CHEMOPREVENTION OF PROSTATE CANCER" project, which aims to conduct preclinical research to support the development of therapies for...
This is a federal contract award to IIT Research Institute by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute. The $2,111,543.00 firm fixed price delivery order is for support related to the aerosol development of the drug bexarotene under the PREVENT Toxicology and Pharmacology Testing (PREVENT TOX) master indefinite delivery/indefinite quantity (IDIQ) contract. IIT Research Institute, the research and technology arm of Illinois...
This federal contract award is for $2,708.00 to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology (IIT), to provide contract orientation and kickoff meeting services for R&D under the "Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications" program. The contract is being issued by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services. IITRI...
This federal contract award is for a two-year base period with a potential one-year extension to support preclinical studies for an LFA-9 (MPGES-1/5-LOX inhibitor) drug candidate. The contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization and division of the Illinois Institute of Technology (IIT). The $1,984,772.00 firm fixed-price...
This is a Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $23,349,236 contract is for the provision of preclinical in vitro and in vivo screening assays to support the development of cancer preventive agents. IITRI, which has extensive experience supporting the preclinical development of various therapeutics for federal...